Literature DB >> 30503133

Using the EngagedMD multimedia platform to improve informed consent for ovulation induction, intrauterine insemination, and in vitro fertilization.

Jody Lyneé Madeira1, Jennifer Rehbein2, Mindy S Christianson3, Miryoung Lee4, J Preston Parry5, Guido Pennings6, Steven R Lindheim7.   

Abstract

OBJECTIVE: To study patient and provider feedback on how a multimedia platform (EngagedMD) helps patients to understand the risks and consequences of in vitro fertilization (IVF), ovulation induction (OI), and intrauterine insemination (IUI) treatments and the impact of the informed consent process.
DESIGN: Prospective survey study.
SETTING: IVF units in the United States. PATIENT(S): Six-thousand three-hundred and thirty-three patients who viewed the multimedia platform before IVF or OI-IUI treatment at 13 U.S. IVF centers and 128 providers. INTERVENTION(S): Quantitative survey with 17 questions. MAIN OUTCOME MEASURE(S): Assessment of the impact of a multimedia platform on patient anxiety, comprehension, and satisfaction and provider/nurse feedback related to the informed consent process. RESULT(S): The survey was completed by 3,097 respondents (66% IVF treatment; 34% OI-IUI treatment) and 44 providers. Overall, 93% felt the media platform was intuitive, and 90% and 95% felt it had appropriate duration and detail, respectively. Most agreed/strongly agreed it better prepared them to consent (88%), increased their comfort in pursuing treatment (77%) and increased their satisfaction with their care (83%). Compared with the OI-IUI group, statistically significantly more participants who viewed the IVF media platform strongly agreed that the comprehension questions reinforced key concepts (47% vs. 40%), educated them about treatment risks (55% vs. 44%), helped them ask providers informed questions (45% vs. 36%), and better prepared them to sign consent forms (46% vs. 37%). Overall, 63% of providers felt that the media platform improved patient learning, made patients more accountable, and standardized information dissemination. CONCLUSION(S): The EngagedMD media platform improves patient knowledge, satisfaction, and control over medical decision making and better prepares patients to give informed consent. Furthermore, it is well-liked by providers and is easily implemented.
Copyright © 2018 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Assisted reproductive technology; informed consent; in vitro fertilization; multimedia platform

Mesh:

Year:  2018        PMID: 30503133     DOI: 10.1016/j.fertnstert.2018.08.045

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  5 in total

1.  Literacy assessment of preimplantation genetic patient education materials exceed national reading levels.

Authors:  Macy L Early; Priyanka Kumar; Arik V Marcell; Cathleen Lawson; Mindy Christianson; Lydia H Pecker
Journal:  J Assist Reprod Genet       Date:  2020-05-29       Impact factor: 3.412

2.  Use of multimedia during informed consent: novelty or necessity.

Authors:  Henry H Chill; Uri Dior; David Shveiky
Journal:  Int Urogynecol J       Date:  2019-07-13       Impact factor: 2.894

3.  Patients' preimplantation genetic testing decision-making experience: an opinion on related psychological frameworks.

Authors:  L M Pastore; C N Cordeiro Mitchell; L R Rubin; J Nicoloro-SantaBarbara; M C Genoff Garzon; M Lobel
Journal:  Hum Reprod Open       Date:  2019-10-04

4.  Learning from Online Video Education (LOVE) improves confidence in fertility treatments: a randomized controlled trial.

Authors:  Amanda Adeleye; Katrina Cruz; Marcelle I Cedars; Lauri Pasch; Heather Huddleston
Journal:  NPJ Digit Med       Date:  2022-08-29

5.  The impact of an interactive multimedia educational platform on patient comprehension and anxiety during fertility treatment: a randomized controlled trial.

Authors:  Abigail L Bernard; Ashley K Barbour; Clare Meernik; Jody L Madeira; Steven R Lindheim; Linnea R Goodman
Journal:  F S Rep       Date:  2022-05-22
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.